2seventy bio, Inc. Given Average Rating of Hold by Brokerages - MarketBeat
| TSVT Stock | USD 2.60 0.12 4.84% |
Slightly above 55% of 2Seventy Bio's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding 2Seventy Bio suggests that some traders are interested. 2Seventy Bio's investing sentiment can be driven by a variety of factors including economic data, 2Seventy Bio's earnings reports, geopolitical events, and overall market trends.
2Seventy |
2seventy bio, Inc. Given Average Rating of Hold by Brokerages MarketBeat
Read at news.google.com
 |
2Seventy Bio Fundamental Analysis
We analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
2Seventy Bio is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
2Seventy Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 2Seventy Bio stock to make a market-neutral strategy. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics with similar companies.
Peers
2Seventy Bio Related Equities
| PHAT | Phathom Pharmaceuticals | 7.10 | ||||
| MRSN | Mersana Therapeutics | 6.25 | ||||
| DAWN | Day One | 4.24 | ||||
| INZY | Inozyme Pharma | 2.75 | ||||
| KZR | Kezar Life | 1.75 | ||||
| SRPT | Sarepta Therapeutics | 1.62 | ||||
| PBYI | Puma Biotechnology | 1.19 | ||||
| PTGX | Protagonist Therapeutics | 0.42 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.23 | ||||
| RLAY | Relay Therapeutics | 0.31 | ||||
| ASND | Ascendis Pharma | 0.74 | ||||
| REPL | Replimune | 0.83 | ||||
| ZNTL | Zentalis Pharmaceuticals | 2.60 | ||||
| IOVA | Iovance Biotherapeutics | 2.97 | ||||
| STOK | Stoke Therapeutics | 5.73 | ||||
| CGEM | Cullinan Oncology | 5.77 | ||||
| SNDX | Syndax Pharmaceuticals | 7.11 | ||||
| RCUS | Arcus Biosciences | 7.71 | ||||
| PLRX | Pliant Therapeutics | 59.88 |
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.